A substantial advancement in diabetes care is emerging with the release of tirzepatide in a 45mg form. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and offers a https://annieuvlv418101.azuria-wiki.com/2246860/revolutionary_approach_tirzepatide_45mg_for_glucose_management